Ansgar Weyergraf

830 total citations
10 papers, 176 citations indexed

About

Ansgar Weyergraf is a scholar working on Dermatology, Immunology and Rheumatology. According to data from OpenAlex, Ansgar Weyergraf has authored 10 papers receiving a total of 176 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Dermatology, 7 papers in Immunology and 3 papers in Rheumatology. Recurrent topics in Ansgar Weyergraf's work include Dermatology and Skin Diseases (8 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and Urticaria and Related Conditions (3 papers). Ansgar Weyergraf is often cited by papers focused on Dermatology and Skin Diseases (8 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and Urticaria and Related Conditions (3 papers). Ansgar Weyergraf collaborates with scholars based in Germany, United States and Netherlands. Ansgar Weyergraf's co-authors include Wolfgang Schulz, Gerhard Schmid‐Ott, Thomas Werfel, Sascha Gerdes, Rotraut Mößner, Dagmar Wilsmann‐Theis, Yvonne Frambach, Sandra Philipp, Bürkard Jäger and Sebastian Rotterdam and has published in prestigious journals such as Journal of the European Academy of Dermatology and Venereology, Dermatology and JDDG Journal der Deutschen Dermatologischen Gesellschaft.

In The Last Decade

Ansgar Weyergraf

10 papers receiving 174 citations

Peers

Ansgar Weyergraf

IMMUN

DERMA

RHEUM

PFM

PMH

Amanda Teeple United States

Paulina M. Young United States

Teresa O'Sullivan United Kingdom

Joachim Koza Switzerland

Cody Connor United States

Robert Higham United States

G. E. van der Kraaij Netherlands

Ray Jobling United Kingdom

Aghdas Ebadi Iran

N. Aszodi Germany

Amanda Teeple United States

Ansgar Weyergraf

265 ×2.0

IMMUN

74 ×0.7

DERMA

22 ×0.8

RHEUM

17 ×0.7

PFM

25 ×1.2

PMH

Citations per year, relative to Ansgar Weyergraf Ansgar Weyergraf (= 1×) peers Amanda Teeple

Countries citing papers authored by Ansgar Weyergraf

Since Specialization

Citations

This map shows the geographic impact of Ansgar Weyergraf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ansgar Weyergraf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ansgar Weyergraf more than expected).

Fields of papers citing papers by Ansgar Weyergraf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ansgar Weyergraf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ansgar Weyergraf. The network helps show where Ansgar Weyergraf may publish in the future.

Co-authorship network of co-authors of Ansgar Weyergraf

This figure shows the co-authorship network connecting the top 25 collaborators of Ansgar Weyergraf. A scholar is included among the top collaborators of Ansgar Weyergraf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ansgar Weyergraf. Ansgar Weyergraf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Weidinger, Stephan, Ansgar Weyergraf, Tobias Hagemann, et al.. (2025). Early Achievement of High Treatment Targets in Moderate-to-Severe Atopic Dermatitis with Upadacitinib: Real-World Evidence from the Observational UP-TAINED Study. Dermatology and Therapy. 15(4). 919–931. 2 indexed citations

2.

Wilsmann‐Theis, Dagmar, Andreas Pinter, Sascha Gerdes, et al.. (2024). Efficacy and safety of guselkumab in European patients with palmoplantar pustulosis: A multi-center, single-arm clinical trial (GAP study). JAAD International. 18. 69–78. 4 indexed citations

3.

Zander, N., M. Krensel, I. Schäfer, et al.. (2019). Sozialrechtliche Ansprüche beim malignen Melanom. Der Hautarzt. 70(10). 804–810. 1 indexed citations

4.

Wilsmann‐Theis, Dagmar, Arnd Jacobi, Yvonne Frambach, et al.. (2017). Palmoplantar pustulosis – a cross-sectional analysis in Germany. Dermatology Online Journal. 23(4). 27 indexed citations

5.

Wilsmann‐Theis, Dagmar, Yvonne Frambach, Sandra Philipp, et al.. (2015). Systemic Antipsoriatic Combination Therapy with Fumaric Acid Esters for Plaque-Type Psoriasis: Report on 17 Cases. Dermatology. 230(2). 119–127. 8 indexed citations

6.

Schulz, Wolfgang, et al.. (2014). Depression und Angststörung bei Psoriasispatienten: Schutz- und Risikofaktoren. Der Hautarzt. 65(12). 1056–1061. 1 indexed citations

7.

Schulz, Wolfgang, et al.. (2014). Depression und Angststörung bei Psoriasispatienten. Der Hautarzt. 65(12). 1056–1061. 24 indexed citations

8.

Werfel, Thomas, et al.. (2012). Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life. Journal of the European Academy of Dermatology and Venereology. 27(2). 220–226. 72 indexed citations

9.

Philipp, Sandra, Dagmar Wilsmann‐Theis, Ansgar Weyergraf, et al.. (2012). Combination of adalimumab with traditional systemic antipsoriatic drugs – a report of 39 cases. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 10(11). 821–837. 29 indexed citations

10.

Philipp, Sandra, Dagmar Wilsmann‐Theis, Ansgar Weyergraf, et al.. (2012). Kombination von Adalimumab mit traditionellen antipsoriatischen Systemtherapeutika – ein Bericht über 39 Fälle. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 10(11). 821–838. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact